Showing results (111-120 of 283) with videos related to
Sort By:
Pageof 29
European Heart Journal. Imaging Methods and Practice|February 20, 2026
Molecular contrast agents for post-infarct cardiac remodelling: a contemporary reviewPak Yin Lam, William D Watson, Ziad Mallat, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|November 1, 2014
Targeting B cells in atherosclerosis: closing the gap from bench to bedsideDimitrios Tsiantoulas, Andrew P Sage, Ziad Mallat, et al.Journal of Immunology Research|November 1, 2016
The CXCL10/CXCR3 Axis and Cardiac Inflammation: Implications for Immunotherapy to Treat Infectious and Noninfectious Diseases of the HeartRaffaele Altara, Ziad Mallat, George W Booz, et al.Nature Medicine|February 8, 2006
Natural regulatory T cells control the development of atherosclerosis in miceHafid Ait-Oufella, Benoît L Salomon, Stéphane Potteaux, et al.Circulation|April 11, 2007
Lactadherin deficiency leads to apoptotic cell accumulation and accelerated atherosclerosis in miceHafid Ait-Oufella, Kiyoka Kinugawa, Joffrey Zoll, et al.Journal of the American College of Cardiology|December 24, 2016
Genetic and Pharmacological Inhibition of TREM-1 Limits the Development of Experimental AtherosclerosisJeremie Joffre, Stephane Potteaux, Lynda Zeboudj, et al.Seminars in Thrombosis and Hemostasis|November 12, 2010
Microparticles: key protagonists in cardiovascular disordersNicolas Amabile, Pierre-Emmanuel Rautou, Alain Tedgui, et al.Frontiers in Cardiovascular Medicine|January 29, 2019
Adaptive Immune Responses Contribute to Post-ischemic Cardiac RemodelingIcia Santos-Zas, Jérémie Lemarié, Alain Tedgui, et al.Antioxidants & Redox Signaling|March 27, 2009
Role of NF-kappaB in flow-induced vascular remodelingYves Castier, Bhama Ramkhelawon, Stéphanie Riou, et al.Circulation Research|January 18, 2014
Microvesicles as cell-cell messengers in cardiovascular diseasesXavier Loyer, Anne-Clémence Vion, Alain Tedgui, et al.Pageof 29